Dr. Rachel Freedman and colleagues discuss how Dana-Farber's Patient Navigator Program addresses BC disparities. For people with metastatic cancer, the constant focus on cure can create a sense of isolation from the cancer community. A study assessed the impact of the COVID-19 pandemic on Black and Hispanic breast cancer (BC) survivors. Researchers observed that the risk of dying from breast cancer in men with HR-positive cancer increased with cancer stage. Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk gene mutations. Dr. Rachel Freedman of Dana-Farber Cancer Institute is joined by colleagues to discuss barriers of cancer in breast cancer. "Rates of post-mastectomy reconstruction in Asian Americans were much lower than non-Asian Americans.” Support interventions are needed for managing oral endocrine therapy-related symptoms among Black breast cancer survivors. Racial disparities exist in the initiation of chemotherapy, with a negative impact on Black women. A study found racial disparities exist in breast cancer imaging therapy. Black women were less likely, and Hispanics were more likely to achieve pathologic complete response to Chemo for TNBC. Prophylactic breast surgery is the most effective way to prevent yourself from getting breast cancer. Diagnoses of breast cancer in women under 50 have shown a consistent rise over the past two decades. Factors such as a systemic mistrust of the health care system may prevent Black women from enrolling in trials for BC. Pathologic complete response to neoadjuvant chemotherapy for TNBC and overall survival differ based on race/ethnicity. Adding a polygenic risk score is effective at predicting breast cancer risk in Black women. Analyzing somatic mutations in Latin American breast cancer patients may play a critical role in treatment planning. Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk gene mutations. The breast cancer recurrence score for recommending adjuvant chemotherapy may be less accurate for Black women. The strong Black woman stereotype is detrimental to the well-being of Black patients with breast and ovarian cancers.